Facts and figures

Placed initially on 4 November 2005 under the former company Biotec Pharmacon, ArcticZymes Technologies ASA is listed on the Oslo Stock Exchange. Being a global leader in development and commercialization of enzymes, we are working continuously on innovative, novel solutions and technologies. Our success stories is not only reflected in our current business figures but also the latest developments on the stock market. Take a look for yourself!


Reports and Finances

Get an insight into our current business developments with our quarterly reports.

Learn more

Shareholder Info

Take a look at the current stock market price and our 20 largest shareholders.

Learn more

Financial Calendar

More financial information

Date Presentation
02 Feb 2023 Presentation of the fourth quarter report 2022 and the preliminary annual accounts 2022
02 May 2023 Annual report 2022
04 May 2023 Presentation of the first quarter 2023
06 Jun 2023 Annual General Meeting
17 Aug 2023 Presentation of the second quarter 2023
02 Nov 2023 Presentation of the third quarter 2023